Search
for

    GlossaryRitlecitinib

    investigational drug targeting enzymes involved in autoimmune hair loss

    Ritlecitinib is an investigational drug that targets specific enzymes known as Janus kinases (JAKs) and TEC family kinases, which are involved in the immune response. It is being studied for its potential to treat autoimmune conditions like alopecia areata, where the immune system mistakenly attacks hair follicles, leading to hair loss.

    Related Terms

    Learn

    5 / 801 results

      learn Tofacitinib

      a JAK inhibitor for alopecia areata and other autoimmune conditions

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Baricitinib

      JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases

    Research

    5 / 492 results

    Community Join

    5 / 1000+ results